RNAi Therapeutics Market Analysis, Size, Share, Growth, Trends, Opportunities and Forecast

An significant RNAi Therapeutics Market research report has been created using a thorough and competent investigation, taking into account the needs of the customer. This outstanding market study assesses the market's current condition, market share and size, revenue from product sales, and necessary modifications that must be made to future items. With the newest technologies, creative programs, and new abilities, it makes the process of gaining insightful market knowledge easier and will undoubtedly help businesses achieve their objectives. A thorough analysis of the product specs, revenue, cost, pricing, gross capacity, and production is also included in the first-rate RNAi Therapeutics Market research.

Explore Further Details about This Research RNAi Therapeutics Market Report https://www.databridgemarketresearch.com/reports/global-rnai-therapeutics-market

According to the World Health Organization estimates that cancer caused 9.6 million deaths in 2018 and is the second-highest cause of death worldwide. About 1 in 6 fatalities worldwide are caused by cancer. Over the following two decades, there will likely be a 70 percent increase in new cases. Additionally, recent developments have made it possible to overcome this barrier and facilitate the clinical use of RNAi-based therapeutics for cancer treatment.

Data Bridge Market Research analyses that the RNAi therapeutics market which was USD 807.99 million in 2022, would rocket up to USD 1645.76 million by 2030, and is expected to undergo a CAGR of 9.3% during the forecast period 2023 to 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

A brand-new class of drugs based on ribonucleic acid is known as RNA therapies (RNA). Target mRNA molecules are neutralized during the biological process known as RNA interference, and RNA molecules are then shown to impede gene expression or translation. Additionally, RNA interference (RNAi) is a group of short RNA-directed processes that inhibits the expression of genes in a sequentially-specific manner.

Drivers

Rising cases of chronic diseases

The rising rates of chronic diseases like cancer, cardiovascular conditions, and others will accelerate market expansion. The RNAi therapeutics market will be further fuelled by additional factors such as rising RNAi therapeutic approvals, advancements in the healthcare sector, rising RD expenditures, and rising pharmaceutical company collaborations during the forecast period of 2023 to 2030.

Increasing collaborative activities

The increasing collaboration activities between drug distribution companies and contract research organizations (CROs) contribute to the growth of the RNAi therapeutics market. Arrowhead Pharmaceuticals Inc and Horizon Therapeutics plc announced a global collaboration and licence agreement for ARO-XDH, a previously undisclosed discovery-stage investigational RNA interference (RNAi) therapeutic being developed by Arrowhead as a potential treatment for people with uncontrolled gout, on June 21, 2021. This collaboration with Horizon also represents an expansion of Arrowhead Pharmaceuticals' rapidly growing pipeline of investigational RNAi therapeutics based on the company's proprietary Targeted RNAi Molecule (TRiMTM) platform." In January 2016, Ionis Pharmaceuticals (previously Isis Pharmaceuticals) began a Phase-I study of ISIS-HBV-L Rx in collaboration with GSK Pharmaceuticals. This acquisition aims to treat Hepatitis B viral infection.

Recent Development

On February 26, 2020, The Brazilian Health Regulatory Agency (ANVISA) approved ONPATTRO for treating hereditary transthyretin-mediated (hATTR) amyloidosis in adults, according to a prominent company's announcement.
In June 2020, OliX Pharmaceuticals and LGC Biosarch Technology agreed to quicken the manufacturing of asymmetric siRNA for treating wet macular degeneration and subretinal fibrosis.

Global RNAi Therapeutics Market Scope

The RNAi therapeutics market is segmented on the basis of molecule type, application, route of administration and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Molecule Type

Small Interfering RNAS
Microrna

Application

Genetic Disorder
Oncology
Neurodegenerative Disorder
Cardiovascular Disorder
Respiratory Disorder
Infectious Disease
Renal Disease
Other

Route of Administration

Intradermal Injections
Pulmonary Delivery
Intravenous Injections
Intraperitoneal Injections
Others

End-User

Diagnostic Laboratories
Research and Academic Laboratories
Hospitals

Some of the major players operating in the RNAi therapeutics market are:

Quark Software Inc. (U.S.)
Hoffmann-La Roche Ltd. (Switzerland)
Rexahn Pharmaceuticals, Inc. (U.S.)
Silence Therapeutics (U.K.)
Arbutus Biopharma (U.S.)
Benitec Biopharma (Australia)
GSK plc (U.K.)
OLIX PHARMACEUTICALS, INC. (South Korea)
Sanofi (France)
Alnylam Pharmaceuticals, Inc. (U.S.)
Moderna Inc. (U.S.)
Ionis Pharmaceuticals (U.S.)

Key questions answered in the RNAi Therapeutics Market are:

What is RNAi Therapeutics Market?
What was the RNAi Therapeutics Market size in 2022?
What are the different segments of the RNAi Therapeutics Market?
What growth strategies are the players considering to increase their presence in RNAi Therapeutics Market?
What are the upcoming industry applications and trends for the RNAi Therapeutics Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the RNAi Therapeutics Market?
What major challenges could the RNAi Therapeutics Market face in the future?
What segments are covered in the RNAi Therapeutics Market?
Who are the leading companies and what are their portfolios in RNAi Therapeutics Market?
What segments are covered in the RNAi Therapeutics Market?
Who are the key players in the RNAi Therapeutics Market?

Browse Related Reports:

Surgical Light Source Market Size and Forecasts, Share and Trends

https://www.databridgemarketresearch.com/reports/global-surgical-light-source-market

Video Microscopes Market Size, Industry Share, Forecast

https://www.databridgemarketresearch.com/reports/global-video-microscopes-market

Needle-Free IV Connectors Market | Size,Share, Growth

https://www.databridgemarketresearch.com/reports/global-needle-free-iv-connectors-market

Infertility Treatment Devices and Equipment Market Size, Trends Growth Analysis

https://www.databridgemarketresearch.com/reports/global-infertility-treatment-devices-and-equipment-market

Orthodontic Bands Market- Global Industry Analysis and Forecast

https://www.databridgemarketresearch.com/reports/global-orthodontic-bands-market

Panniculitis Market Value | Size,Trends,Forecast|